Short interest in Verve Therapeutics Inc (NASDAQ:VERV) increased during the last reporting period, rising from 17.08M to 17.87M. This put 25.21% of the company's publicly available shares short.

Short interest for Verve Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Verve Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.57M shares traded per day, it would take 11.37 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.